Recombinant Human KIR2DL3/CD158b2 Fc Chimera Protein, CF
Description
Purity >90%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 66-75 kDa, reducing conditions. MW (theoretical): 51.2 kDa (monomer). The Recombinant Human KIR2DL3/CD158b2 Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human KIR2DL3/CD158b2 Fc Chimera Protein has been validated for the following applications: Bioactivity.
Size
50 ug
Concentration
n/a
Applications
Bioactivity
Other Names
CD158 antigen-like family member B2, CD158b2, CD158b2 antigen, CD158B2CD158b, cl-6, killer cell immunoglobulin-like receptor 2DL3, killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3, Killer inhibitory receptor cl 2-3, KIR-023GB, KIRCL23, KIR-K7b, KIR-K7c, MGC129943, MHC class I NK cell receptor, natural killer associated transcript 2, natural killer cell inhibitory receptor KIR2DL3, Natural killer-associated transcript 2, NKAT, nkat2, NKAT-2, nkat2a, NKAT2B, NKAT2GL183, NK-receptor, p58, p58 natural killer cell receptor clone CL-6, p58 NK receptor CL-6, p58.2 MHC class-I specific NK receptor, p58.2 MHC class-I-specific NK receptor